Clinical presentation and natural history 789ДЎ0.4 Revascularization options: general aspects 791ДЎ0.5 Management of intermittent claudication 791ДЎ0.5.2 Pharmacotherapy to decrease walking impairment 792ДЎ0.5.3 Revascularization for intermittent claudication 792ДЎ0.5.4 Management strategy for intermittent claudication 792ДЎ0.6 Chronic limb-threatening ischaemia 795ДЎ0.6.1 Chronic limb-threatening ischaemia severity and risk stratification: the WIfI classification 795ДЎ0.6.2 Management of patients with chronic limb-threatening ischaemia 795ДЎ1.1 Multisite artery disease: epidemiology and impact prognosis 800ДЎ1.2 Screening for and management of multisite artery disease 800ДЎ1.2.1 Peripheral arterial diseases in patients presenting with coronary artery disease 800ДЎ1.2.2.

Extracranial carotid and vertebral artery disease 778Д¦.1.4 Management of carotid artery disease 779Д¦.2.3 Management of vertebral artery disease 783Д§.4.2 Computed tomography angiography 783Д§.4.4 Digital subtraction angiography 783ДЁ.2 Chronic mesenteric artery disease 785ДЎ0.1. The Addenda and Questions and Answers companion documents of these guidelines are available at: Web AddendaДЇor the Web Addenda which include background information and detailed discussion of the data that have provided the basis for the recommendations see ESC CardioMed SectionД¬urrent background information and detailed discussion of the data for these Guidelines can be found in ESC CardioMed - Section 49 Peripheral arterial diseases Table of contentsДҐ.1 Antithrombotic treatment in carotid artery disease 773ДҐ.2 Antithrombotic therapy in lower extremity artery disease 774ДҐ.2.2 Dual and triple antiplatelet therapy 774ДҐ.2.3 Antithrombotic therapy after lower-extremity bypass grafting 774ДҐ.2.4 Antithrombotic drugs after endovascular therapy for lower extremity artery disease 775ДҐ.2.5 Patients with lower extremity artery disease and concomitant coronary artery disease 775ДҐ.3 Antithrombotic therapy in lower extremity artery disease patients requiring long-term oral anticoagulant 776ДҐ.4 Antithrombotic therapy after endovascular therapy in other territories 777Д¦. The disclosure forms of all experts involved in the development of these guidelines are available on the ESC website. Guidelines, Peripheral arterial diseases, Carotid artery disease, Vertebral artery disease, Upper extremity artery disease, Mesenteric artery disease, Renal artery disease, Lower extremity artery disease, Multisite artery disease The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS), European Heart Journal, Volume 39, Issue 9, 01 March 2018, Pages 763вЂ“816, Victor Aboyans, Jean-Baptiste Ricco, Marie-Louise E L Bartelink, Martin BjГ¶rck, Marianne Brodmann, Tina Cohnert, Jean-Philippe Collet, Martin Czerny, Marco De Carlo, Sebastian Debus, Christine Espinola-Klein, Thomas Kahan, Serge Kownator, Lucia Mazzolai, A Ross Naylor, Marco Roffi, Joachim RГ¶ther, Muriel Sprynger, Michal Tendera, Gunnar Tepe, Maarit Venermo, Charalambos Vlachopoulos, Ileana Desormais, ESC Scientific Document Group, 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesД®ndorsed by: the European Stroke Organization (ESO)

Atv flash black 2.6.1 free 2018